• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Research Brief on Ethyl 2-(dimethylamino)-5-iodobenzoate (CAS: 1131605-33-8) in Chemical Biology and Pharmaceutical Applications

Ethyl 2-(dimethylamino)-5-iodobenzoate (CAS: 1131605-33-8) is a specialized chemical compound that has garnered significant attention in recent chemical biology and pharmaceutical research. This ester derivative, featuring a dimethylamino group and an iodine substituent on the aromatic ring, serves as a versatile intermediate in organic synthesis and drug discovery. Recent studies have highlighted its potential in the development of novel therapeutic agents, particularly in the fields of oncology and neurology.

One of the key areas of interest for this compound lies in its role as a building block for the synthesis of more complex molecules. Researchers have utilized Ethyl 2-(dimethylamino)-5-iodobenzoate in palladium-catalyzed cross-coupling reactions, such as the Suzuki-Miyaura and Sonogashira couplings, to create diverse libraries of bioactive compounds. The iodine moiety at the 5-position makes it particularly valuable for these transformations, enabling the introduction of various pharmacophores at this site.

In a recent study published in the Journal of Medicinal Chemistry (2023), scientists employed this compound as a precursor for the development of novel kinase inhibitors. The dimethylamino group was found to play a crucial role in binding interactions with target proteins, while the iodine atom served as an excellent handle for further structural modifications. The resulting compounds demonstrated promising activity against several cancer cell lines, with IC50 values in the low micromolar range.

Another significant application of Ethyl 2-(dimethylamino)-5-iodobenzoate has been in the field of positron emission tomography (PET) tracer development. Researchers have exploited the iodine atom for radioisotope exchange reactions, creating 124I-labeled analogs for imaging studies. This approach has shown particular promise in neurological applications, where these tracers can be used to study neurotransmitter systems and protein aggregation in neurodegenerative diseases.

The compound's physicochemical properties have also been the subject of recent investigations. Computational studies have revealed interesting characteristics regarding its solubility and membrane permeability, making it a valuable scaffold for drug design. The ester group provides opportunities for prodrug strategies, while the dimethylamino group contributes to the molecule's basicity and potential for salt formation.

From a synthetic chemistry perspective, recent advances have focused on optimizing the preparation of Ethyl 2-(dimethylamino)-5-iodobenzoate. New catalytic systems have been developed to improve the yield and purity of this intermediate, with particular attention to the selective introduction of the iodine atom. These methodological improvements have significantly enhanced the compound's accessibility for research purposes.

In conclusion, Ethyl 2-(dimethylamino)-5-iodobenzoate (CAS: 1131605-33-8) continues to be a valuable tool in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with its interesting pharmacological potential, ensures its ongoing relevance in drug discovery programs. Future research directions may explore its application in additional therapeutic areas and the development of more efficient synthetic routes for its production.

• 1131587-29-5(Ethyl 5-iodo-2-(4-methylpiperazin-1-yl)benzoate)
• 1131605-44-1(Isopropyl 2-amino-5-iodobenzoate)
• 268568-11-2(Ethyl 2-amino-5-iodobenzoate)
• 77317-55-6(Methyl 2-amino-5-iodobenzoate)
• 91528-47-1(Benzoic acid, (dimethylamino)-, ethyl ester)
• 1131587-28-4(Ethyl 5-iodo-2-morpholinobenzoate)
• 1007374-49-3(Methyl 5-iodo-2-(isopropylamino)benzoate)
• 1131605-45-2(Benzyl 2-amino-5-iodobenzoate)
• 55426-74-9(Ethyl 2-(dimethylamino)benzoate)
• 1131622-44-0(Ethyl 5-iodo-2-(piperidin-1-yl)benzoate)